The multicentre unsustained tachycardia trial, or MUSTT, compared an electrophysiologically guided strategy with no antiarrhythmic therapy. |
|
Although class III antiarrhythmic agents can suppress ventricular arrhythmias, they are also associated with torsade de pointes. |
|
In the arrhythmic patients, the antiarrhythmic treatment was gradually reduced, and in patients 1, 3, and 9, it was withdrawn. |
|
Bretylium tosylate is an IVRB adrenergic blocking agent that also is used as an antiarrhythmic. |
|
These patients should be treated with a beta blocker or class I antiarrhythmic drug. |
|
The relapse rate after cardioversion is high and often necessitates the use of antiarrhythmic treatment. |
|
Multaq contains the medicinal ingredient dronedarone classified as an antiarrhythmic agent. |
|
In the mid-1970s the calcium channel blockers, another type of antiarrhythmic drug, were introduced. |
|
To prevent recurrences, which are extremely frequent, this is generally followed by treatment with an antiarrhythmic drug. |
|
The sustained condition of atrial flutter is treated with electric countershock followed by antiarrhythmic therapy to maintain normal rhythm. |
|
Patients receiving more than one antiarrhythmic drug must be carefully monitored. |
|
As soon as possible, and when indicated, patients should be changed to an oral antiarrhythmic agent for maintenance therapy. |
|
Quinidine, procainamide, lidocaine, and phenytoin exert their antiarrhythmic effects by reducing electrical excitability. |
|
No antiarrhythmic drug has been shown to reduce the incidence of sudden death in patients with asymptomatic ventricular arrhythmias. |
|
The continued need for the other antiarrhythmic agent should be reviewed after the effects of amiodarone have been established, and discontinuation ordinarily should be attempted. |
|
Amiodarone is a class III antiarrhythmic drug widely used for both ventricular and supraventricular tachyarrhythmias. |
|
Multiple ectopic beats that are causing palpitations, or that occur after a myocardial infarction, can be treated with an antiarrhythmic drug. |
|
The medication causes antiarrhythmic and antianginal effects. |
|
However, it has been demonstrated to exert an antiarrhythmic effect by increasing the electrical stimulation threshold of the ventricle during diastole. |
|
Attempts to substitute other antiarrhythmic agents when amiodarone must be stopped will be made difficult by the gradually, but unpredictably, changing amiodarone body burden. |
|
|
In amiodarone-treated patients who require additional antiarrhythmic therapy, the initial dose of such agents should be approximately half of the usual recommended dose. |
|
In light of the above, physicians should carefully consider the risks and benefits of antiarrhythmic therapy for all patients with ventricular arrhythmias. |
|
A larger oral loading dose of the antiarrhythmic may be required. |
|
In patients suffering from atrial fibrillation, the phase III trials EURIDIS and ADONIS demonstrated the good efficacy and safety of dronedarone used as an antiarrhythmic. |
|
Dronedarone, a new class III antiarrhythmic agent, is a noniodinated amiodarone derivative associated with fewer adverse effects and reduced toxicity. |
|
Hydralazine, a vasodilator for hypertension, and procainamide, an antiarrhythmic sodium channel blocker, inhibit DNA methylation and thereby affect the epigenome. |
|
We report a case of torsades de pointes that developed when amiodarone, a class III antiarrhythmic, was added to a drug regimen that included the fluoroquinolone levofloxacin. |
|
The drugs are grouped into 12 chapters such as renin-angiotensin-aldosterone system antagonists, calcium channel blockers, lipid-lowering agents, and antiarrhythmic drugs. |
|
Our study aimed at to shed a light on the issue to investigate the antiarrhythmic effects of matrine by using ouabain to construct an arrhythmic model of cardiomyocytes. |
|